Apellis Pharmaceuticals Stock Target Price and Analyst Consensus
| APLS Stock | USD 30.77 3.02 10.88% |
The current analyst and expert consensus on Apellis Pharmaceuticals is Strong Buy with 6 hold recommendations. The current projected Apellis Pharmaceuticals target price consensus is 71.71 with 21 analyst opinions. One of the most common ways Apellis Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Apellis Pharmaceuticals vendors, executives, and/or customers. Apellis Pharmaceuticals recommendation module provides expert sentiment on the projected Apellis Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 3.4436.
Lowest Forecast 65.26 | Highest Forecast 79.6 | Target Price 71.71 |
Apellis |
It's important to approach Apellis Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Apellis Pharmaceuticals price targets
Apellis Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Apellis Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Apellis Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Apellis Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Apellis Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Apellis Pharmaceuticals is a key component of Apellis Pharmaceuticals valuation and have some predictive power on the future returns of a Apellis Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Investor Favorites Invested few shares | |
 | Social Domain Invested few shares | |
 | Driverless Cars Invested over 50 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Chemicals Invested over 30 shares | |
 | ESG Investing Invested few shares |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.